This website uses cookies and similar technologies (hereinafter collectively referred to as ‘cookies’). We may use cookies for the following purposes:
With the buttons below, you can choose which cookies you wish to accept. On our cookie statement page, you can manage your cookie preferences. You can always withdraw your consent for cookies by making different choices there. For more information about cookies, please refer to our cookie statement.
AkzoNobel recently announced that it's CEO Ton Büchner will be absent for a few weeks due to sick-leave. Probably this has scared investors. The author of this article, Cees van Riel, gives his view on the matter.
AkzoNobel recently announced that it's CEO Ton Büchner will be absent for a few weeks due to sick-leave. Probably this has scared investors. The author of this article, Cees van Riel, gives his view on the matter.